Pillar 9 of 9

Culture, Ethics, and Society

Psychedelic medicines have indigenous lineages spanning thousands of years: ayahuasca in the Amazon, peyote in northern Mexico and the southwestern US, psilocybin mushrooms in Mesoamerica, iboga in Central Africa. The contemporary movement of these medicines into Western clinics, retreats, and decriminalized markets raises questions about reciprocity, intellectual property, ecological sustainability, equitable access, and what "informed consent" means when an experience can reshape identity.

In this pillar

10 topics

Comparisons

Understanding the differences and similarities between psychedelic substances, covering pharmacology, duration, intensity, cultural context, and choosing based on intention.

Cultural Appropriation

The specific ethical concerns around adopting indigenous psychedelic ceremonial practices - what appropriation means in this context, who is harmed, and what responsible engagement looks like.

Decriminalization Movements

The rapid growth of decriminalization movements for psychedelic substances - how decriminalization differs from legalization, what has passed where, and what these policy shifts mean.

History of Psychedelics

The long arc of humanity's relationship with psychedelic substances, from indigenous traditions through the mid-century research wave, prohibition, and the current renaissance.

Indigenous Traditions

The living indigenous traditions from which most psychedelic medicines derive - the diversity of these traditions, what they understand about the medicines, and the ethical questions their appropriation raises.

Legal Landscape

The evolving legal status of psychedelic substances worldwide, covering scheduling, decriminalization, medical exemptions, and religious use protections.

Medicalization and Commodification

The benefits and risks of turning psychedelic medicines into regulated medical treatments - standardization, commodification, access equity, and what may be lost in translation.

Religious Use and Protections

How religious communities have used and protected psychedelic substances - from Native American Church peyote rights to the UDV Supreme Court case to the ongoing relationship between mystical experience and therapeutic outcomes.

The Ethics of Access

The deep inequalities in who can access psychedelic medicines - economic barriers to clinical therapy, racial disparities in research, and indigenous communities' complex relationship to the commercialization of their traditions.

Women and Psychedelics

How the psychedelic experiences of women differ in physiology, safety considerations, and therapeutic contexts - and the documented safety concerns around ceremonial settings that require honest attention.

Continue exploring